BeiGene | Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function

⟵ Back to Search Results

Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function

Beigene Study ID

BGB-3111-107

ClinicalTrials.gov ID

NCT03465059

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Sex: All

Age: 18 Years / 75 Years

No Study Documents